<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    NowKeto, Inc.

    NowKeto, Inc.

    NowKeto wants to empower people to live the ketogenic lifestyle through their diet...

    NowKeto wants to empower people to live the ket...

    Amount Raised:    $25,623.00
    Fundraising Status:    EC
    Filing Type:    CF
    BioCardia, Inc.

    BioCardia, Inc.

    BioCardia, Inc., headquartered in San Carlos, California, is developing regenerati...

    BioCardia, Inc., headquartered in San Carlos, C...

    Filing Type:    PU
    PlantPharm BioMed, Ltd.

    PlantPharm BioMed, Ltd.

    We are a global frontrunner in making oral vaccines a reality. We’ve created a p...

    We are a global frontrunner in making oral vacc...

    Amount Raised:    $0.00
    Fundraising Status:    EC
    Filing Type:    CF
    Fresenius SE & Co. KGaA

    Fresenius SE & Co. KGaA

    Fresenius is a global healthcare group offering high-quality products and services...

    Fresenius is a global healthcare group offering...

    Filing Type:    PU
    Solid Biosciences Inc.

    Solid Biosciences Inc.

    Solid Biosciences is a life science company focused solely on finding meaningful t...

    Solid Biosciences is a life science company foc...

    Filing Type:    PU
    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    NantKwest, Inc.

    NantKwest, Inc.

    NantKwest is an innovative clinical-stage immunotherapy company focused on harness...

    NantKwest is an innovative clinical-stage immun...

    Filing Type:    PU
    Atreca, Inc.

    Atreca, Inc.

    Atreca is a biotechnology company developing novel therapeutics drawn from human i...

    Atreca is a biotechnology company developing no...

    Filing Type:    PU
    Jounce Therapeutics, Inc.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transfo...

    Jounce Therapeutics is a clinical stage immunot...

    Filing Type:    PU
    Neon Therapeutics, Inc.

    Neon Therapeutics, Inc.

    Neon Therapeutics is a clinical-stage immuno-oncology company leading in the field...

    Neon Therapeutics is a clinical-stage immuno-on...

    Filing Type:    PU
    Cellectis S.A.

    Cellectis S.A.

    Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune ...

    Cellectis is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Tyme Technologies, Inc.

    Tyme Technologies, Inc.

    Tyme Inc. is an emerging biotechnology company developing cancer therapeutics that...

    Tyme Inc. is an emerging biotechnology company ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.